Stuart Lutzker
Vermogen: 5 M $ op 30-06-2026
Vermogen: 5 M $ op 30-06-2026
Stuart Lutzker is the founder of Arrivent BioPharma, Inc., founded in 2021, holding the titles of Director and President-Research & Development since 2022.
Former job includes VP, Head-Oncology & Early Clinical Development at Genentech, Inc. from 2004 to 2021.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and a doctorate from Columbia University College of Physicians & Surgeons.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2026 | 147.744 ( 0,32% ) | 5 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Oprichter | 14-04-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-03-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau